Global Sickle Cell Disease Drug Market Professional Survey Report 2018

Table of Contents

Global Sickle Cell Disease Drug Market Professional Survey Report 2018
1 Industry Overview of Sickle Cell Disease Drug
1.1 Definition and Specifications of Sickle Cell Disease Drug
1.1.1 Definition of Sickle Cell Disease Drug
1.1.2 Specifications of Sickle Cell Disease Drug
1.2 Classification of Sickle Cell Disease Drug
1.2.1 ARQ-092
1.2.2 BIVV-003
1.2.3 CAL-H
1.2.4 CTX-001
1.2.5 DRX-194
1.2.6 Others
1.3 Applications of Sickle Cell Disease Drug
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Others
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India

2 Manufacturing Cost Structure Analysis of Sickle Cell Disease Drug
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Sickle Cell Disease Drug
2.3 Manufacturing Process Analysis of Sickle Cell Disease Drug
2.4 Industry Chain Structure of Sickle Cell Disease Drug

3 Technical Data and Manufacturing Plants Analysis of Sickle Cell Disease Drug
3.1 Capacity and Commercial Production Date of Global Sickle Cell Disease Drug Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global Sickle Cell Disease Drug Major Manufacturers in 2017
3.3 R&D Status and Technology Source of Global Sickle Cell Disease Drug Major Manufacturers in 2017
3.4 Raw Materials Sources Analysis of Global Sickle Cell Disease Drug Major Manufacturers in 2017

4 Global Sickle Cell Disease Drug Overall Market Overview
4.1 2013-2018E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2013-2018E Global Sickle Cell Disease Drug Capacity and Growth Rate Analysis
4.2.2 2017 Sickle Cell Disease Drug Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2013-2018E Global Sickle Cell Disease Drug Sales and Growth Rate Analysis
4.3.2 2017 Sickle Cell Disease Drug Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2013-2018E Global Sickle Cell Disease Drug Sales Price
4.4.2 2017 Sickle Cell Disease Drug Sales Price Analysis (Company Segment)

5 Sickle Cell Disease Drug Regional Market Analysis
5.1 North America Sickle Cell Disease Drug Market Analysis
5.1.1 North America Sickle Cell Disease Drug Market Overview
5.1.2 North America 2013-2018E Sickle Cell Disease Drug Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2013-2018E Sickle Cell Disease Drug Sales Price Analysis
5.1.4 North America 2017 Sickle Cell Disease Drug Market Share Analysis
5.2 China Sickle Cell Disease Drug Market Analysis
5.2.1 China Sickle Cell Disease Drug Market Overview
5.2.2 China 2013-2018E Sickle Cell Disease Drug Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2013-2018E Sickle Cell Disease Drug Sales Price Analysis
5.2.4 China 2017 Sickle Cell Disease Drug Market Share Analysis
5.3 Europe Sickle Cell Disease Drug Market Analysis
5.3.1 Europe Sickle Cell Disease Drug Market Overview
5.3.2 Europe 2013-2018E Sickle Cell Disease Drug Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2013-2018E Sickle Cell Disease Drug Sales Price Analysis
5.3.4 Europe 2017 Sickle Cell Disease Drug Market Share Analysis
5.4 Southeast Asia Sickle Cell Disease Drug Market Analysis
5.4.1 Southeast Asia Sickle Cell Disease Drug Market Overview
5.4.2 Southeast Asia 2013-2018E Sickle Cell Disease Drug Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2013-2018E Sickle Cell Disease Drug Sales Price Analysis
5.4.4 Southeast Asia 2017 Sickle Cell Disease Drug Market Share Analysis
5.5 Japan Sickle Cell Disease Drug Market Analysis
5.5.1 Japan Sickle Cell Disease Drug Market Overview
5.5.2 Japan 2013-2018E Sickle Cell Disease Drug Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2013-2018E Sickle Cell Disease Drug Sales Price Analysis
5.5.4 Japan 2017 Sickle Cell Disease Drug Market Share Analysis
5.6 India Sickle Cell Disease Drug Market Analysis
5.6.1 India Sickle Cell Disease Drug Market Overview
5.6.2 India 2013-2018E Sickle Cell Disease Drug Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2013-2018E Sickle Cell Disease Drug Sales Price Analysis
5.6.4 India 2017 Sickle Cell Disease Drug Market Share Analysis

6 Global 2013-2018E Sickle Cell Disease Drug Segment Market Analysis (by Type)
6.1 Global 2013-2018E Sickle Cell Disease Drug Sales by Type
6.2 Different Types of Sickle Cell Disease Drug Product Interview Price Analysis
6.3 Different Types of Sickle Cell Disease Drug Product Driving Factors Analysis
6.3.1 ARQ-092 of Sickle Cell Disease Drug Growth Driving Factor Analysis
6.3.2 BIVV-003 of Sickle Cell Disease Drug Growth Driving Factor Analysis
6.3.3 CAL-H of Sickle Cell Disease Drug Growth Driving Factor Analysis
6.3.4 CTX-001 of Sickle Cell Disease Drug Growth Driving Factor Analysis
6.3.5 DRX-194 of Sickle Cell Disease Drug Growth Driving Factor Analysis
6.3.6 Others of Sickle Cell Disease Drug Growth Driving Factor Analysis

7 Global 2013-2018E Sickle Cell Disease Drug Segment Market Analysis (by Application)
7.1 Global 2013-2018E Sickle Cell Disease Drug Consumption by Application
7.2 Different Application of Sickle Cell Disease Drug Product Interview Price Analysis
7.3 Different Application of Sickle Cell Disease Drug Product Driving Factors Analysis
7.3.1 Hospital of Sickle Cell Disease Drug Growth Driving Factor Analysis
7.3.2 Clinic of Sickle Cell Disease Drug Growth Driving Factor Analysis
7.3.3 Others of Sickle Cell Disease Drug Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Sickle Cell Disease Drug
8.1 Acceleron Pharma Inc
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Acceleron Pharma Inc 2017 Sickle Cell Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Acceleron Pharma Inc 2017 Sickle Cell Disease Drug Business Region Distribution Analysis
8.2 Addmedica SAS
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Addmedica SAS 2017 Sickle Cell Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Addmedica SAS 2017 Sickle Cell Disease Drug Business Region Distribution Analysis
8.3 Angiocrine Bioscience Inc
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Angiocrine Bioscience Inc 2017 Sickle Cell Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Angiocrine Bioscience Inc 2017 Sickle Cell Disease Drug Business Region Distribution Analysis
8.4 Annexin Pharmaceuticals AB
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Annexin Pharmaceuticals AB 2017 Sickle Cell Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Annexin Pharmaceuticals AB 2017 Sickle Cell Disease Drug Business Region Distribution Analysis
8.5 ArQule Inc
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 ArQule Inc 2017 Sickle Cell Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 ArQule Inc 2017 Sickle Cell Disease Drug Business Region Distribution Analysis
8.6 Bio Products Laboratory Ltd
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Bio Products Laboratory Ltd 2017 Sickle Cell Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Bio Products Laboratory Ltd 2017 Sickle Cell Disease Drug Business Region Distribution Analysis
8.7 Bioverativ Inc
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Bioverativ Inc 2017 Sickle Cell Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Bioverativ Inc 2017 Sickle Cell Disease Drug Business Region Distribution Analysis
8.8 bluebird bio Inc
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 bluebird bio Inc 2017 Sickle Cell Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 bluebird bio Inc 2017 Sickle Cell Disease Drug Business Region Distribution Analysis
8.9 Bristol-Myers Squibb Co
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Bristol-Myers Squibb Co 2017 Sickle Cell Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Bristol-Myers Squibb Co 2017 Sickle Cell Disease Drug Business Region Distribution Analysis
8.10 Calimmune Inc
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 Calimmune Inc 2017 Sickle Cell Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Calimmune Inc 2017 Sickle Cell Disease Drug Business Region Distribution Analysis
8.11 CRISPR Therapeutics
8.12 CSL Ltd
8.13 Daiichi Sankyo Co Ltd
8.14 Editas Medicine Inc
8.15 Errant Gene Therapeutics LLC
8.16 Gamida Cell Ltd
8.17 Genethon SA
8.18 Gilead Sciences Inc
8.19 Global Blood Therapeutics Inc

9 Development Trend of Analysis of Sickle Cell Disease Drug Market
9.1 Global Sickle Cell Disease Drug Market Trend Analysis
9.1.1 Global 2018-2025 Sickle Cell Disease Drug Market Size (Volume and Value) Forecast
9.1.2 Global 2018-2025 Sickle Cell Disease Drug Sales Price Forecast
9.2 Sickle Cell Disease Drug Regional Market Trend
9.2.1 North America 2018-2025 Sickle Cell Disease Drug Consumption Forecast
9.2.2 China 2018-2025 Sickle Cell Disease Drug Consumption Forecast
9.2.3 Europe 2018-2025 Sickle Cell Disease Drug Consumption Forecast
9.2.4 Southeast Asia 2018-2025 Sickle Cell Disease Drug Consumption Forecast
9.2.5 Japan 2018-2025 Sickle Cell Disease Drug Consumption Forecast
9.2.6 India 2018-2025 Sickle Cell Disease Drug Consumption Forecast
9.3 Sickle Cell Disease Drug Market Trend (Product Type)
9.4 Sickle Cell Disease Drug Market Trend (Application)

10 Sickle Cell Disease Drug Marketing Type Analysis
10.1 Sickle Cell Disease Drug Regional Marketing Type Analysis
10.2 Sickle Cell Disease Drug International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Sickle Cell Disease Drug by Region
10.4 Sickle Cell Disease Drug Supply Chain Analysis

11 Consumers Analysis of Sickle Cell Disease Drug
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 Conclusion of the Global Sickle Cell Disease Drug Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source



List of Tables and Figures
Figure Picture of Sickle Cell Disease Drug
Table Product Specifications of Sickle Cell Disease Drug
Table Classification of Sickle Cell Disease Drug
Figure Global Production Market Share of Sickle Cell Disease Drug by Type in 2017
Figure ARQ-092 Picture
Table Major Manufacturers of ARQ-092
Figure BIVV-003 Picture
Table Major Manufacturers of BIVV-003
Figure CAL-H Picture
Table Major Manufacturers of CAL-H
Figure CTX-001 Picture
Table Major Manufacturers of CTX-001
Figure DRX-194 Picture
Table Major Manufacturers of DRX-194
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of Sickle Cell Disease Drug
Figure Global Consumption Volume Market Share of Sickle Cell Disease Drug by Application in 2017
Figure Hospital Examples
Table Major Consumers in Hospital
Figure Clinic Examples
Table Major Consumers in Clinic
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Sickle Cell Disease Drug by Regions
Figure North America Sickle Cell Disease Drug Market Size (Million USD) (2013-2025)
Figure China Sickle Cell Disease Drug Market Size (Million USD) (2013-2025)
Figure Europe Sickle Cell Disease Drug Market Size (Million USD) (2013-2025)
Figure Southeast Asia Sickle Cell Disease Drug Market Size (Million USD) (2013-2025)
Figure Japan Sickle Cell Disease Drug Market Size (Million USD) (2013-2025)
Figure India Sickle Cell Disease Drug Market Size (Million USD) (2013-2025)
Table Sickle Cell Disease Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Sickle Cell Disease Drug in 2017
Figure Manufacturing Process Analysis of Sickle Cell Disease Drug
Figure Industry Chain Structure of Sickle Cell Disease Drug
Table Capacity and Commercial Production Date of Global Sickle Cell Disease Drug Major Manufacturers in 2017
Table Manufacturing Plants Distribution of Global Sickle Cell Disease Drug Major Manufacturers in 2017
Table R&D Status and Technology Source of Global Sickle Cell Disease Drug Major Manufacturers in 2017
Table Raw Materials Sources Analysis of Global Sickle Cell Disease Drug Major Manufacturers in 2017
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Sickle Cell Disease Drug 2013-2018E
Figure Global 2013-2018E Sickle Cell Disease Drug Market Size (Volume) and Growth Rate
Figure Global 2013-2018E Sickle Cell Disease Drug Market Size (Value) and Growth Rate
Table 2013-2018E Global Sickle Cell Disease Drug Capacity and Growth Rate
Table 2017 Global Sickle Cell Disease Drug Capacity (K Pcs) List (Company Segment)
Table 2013-2018E Global Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate
Table 2017 Global Sickle Cell Disease Drug Sales (K Pcs) List (Company Segment)
Table 2013-2018E Global Sickle Cell Disease Drug Sales Price (USD/Pcs)
Table 2017 Global Sickle Cell Disease Drug Sales Price (USD/Pcs) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Pcs) of Sickle Cell Disease Drug 2013-2018E
Figure North America 2013-2018E Sickle Cell Disease Drug Sales Price (USD/Pcs)
Figure North America 2017 Sickle Cell Disease Drug Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Pcs) of Sickle Cell Disease Drug 2013-2018E
Figure China 2013-2018E Sickle Cell Disease Drug Sales Price (USD/Pcs)
Figure China 2017 Sickle Cell Disease Drug Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Pcs) of Sickle Cell Disease Drug 2013-2018E
Figure Europe 2013-2018E Sickle Cell Disease Drug Sales Price (USD/Pcs)
Figure Europe 2017 Sickle Cell Disease Drug Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Pcs) of Sickle Cell Disease Drug 2013-2018E
Figure Southeast Asia 2013-2018E Sickle Cell Disease Drug Sales Price (USD/Pcs)
Figure Southeast Asia 2017 Sickle Cell Disease Drug Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Pcs) of Sickle Cell Disease Drug 2013-2018E
Figure Japan 2013-2018E Sickle Cell Disease Drug Sales Price (USD/Pcs)
Figure Japan 2017 Sickle Cell Disease Drug Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Pcs) of Sickle Cell Disease Drug 2013-2018E
Figure India 2013-2018E Sickle Cell Disease Drug Sales Price (USD/Pcs)
Figure India 2017 Sickle Cell Disease Drug Sales Market Share
Table Global 2013-2018E Sickle Cell Disease Drug Sales (K Pcs) by Type
Table Different Types Sickle Cell Disease Drug Product Interview Price
Table Global 2013-2018E Sickle Cell Disease Drug Sales (K Pcs) by Application
Table Different Application Sickle Cell Disease Drug Product Interview Price
Table Acceleron Pharma Inc Information List
Table Product A Overview
Table Product B Overview
Table 2017 Acceleron Pharma Inc Sickle Cell Disease Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2017 Acceleron Pharma Inc Sickle Cell Disease Drug Business Region Distribution
Table Addmedica SAS Information List
Table Product A Overview
Table Product B Overview
Table 2017 Addmedica SAS Sickle Cell Disease Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2017 Addmedica SAS Sickle Cell Disease Drug Business Region Distribution
Table Angiocrine Bioscience Inc Information List
Table Product A Overview
Table Product B Overview
Table 2015 Angiocrine Bioscience Inc Sickle Cell Disease Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2017 Angiocrine Bioscience Inc Sickle Cell Disease Drug Business Region Distribution
Table Annexin Pharmaceuticals AB Information List
Table Product A Overview
Table Product B Overview
Table 2017 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2017 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Business Region Distribution
Table ArQule Inc Information List
Table Product A Overview
Table Product B Overview
Table 2017 ArQule Inc Sickle Cell Disease Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2017 ArQule Inc Sickle Cell Disease Drug Business Region Distribution
Table Bio Products Laboratory Ltd Information List
Table Product A Overview
Table Product B Overview
Table 2017 Bio Products Laboratory Ltd Sickle Cell Disease Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2017 Bio Products Laboratory Ltd Sickle Cell Disease Drug Business Region Distribution
Table Bioverativ Inc Information List
Table Product A Overview
Table Product B Overview
Table 2017 Bioverativ Inc Sickle Cell Disease Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2017 Bioverativ Inc Sickle Cell Disease Drug Business Region Distribution
Table bluebird bio Inc Information List
Table Product A Overview
Table Product B Overview
Table 2017 bluebird bio Inc Sickle Cell Disease Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2017 bluebird bio Inc Sickle Cell Disease Drug Business Region Distribution
Table Bristol-Myers Squibb Co Information List
Table Product A Overview
Table Product B Overview
Table 2017 Bristol-Myers Squibb Co Sickle Cell Disease Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2017 Bristol-Myers Squibb Co Sickle Cell Disease Drug Business Region Distribution
Table Calimmune Inc Information List
Table Product A Overview
Table Product B Overview
Table 2017 Calimmune Inc Sickle Cell Disease Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2017 Calimmune Inc Sickle Cell Disease Drug Business Region Distribution
Table CRISPR Therapeutics Information List
Table CSL Ltd Information List
Table Daiichi Sankyo Co Ltd Information List
Table Editas Medicine Inc Information List
Table Errant Gene Therapeutics LLC Information List
Table Gamida Cell Ltd Information List
Table Genethon SA Information List
Table Gilead Sciences Inc Information List
Table Global Blood Therapeutics Inc Information List
Figure Global 2018-2025 Sickle Cell Disease Drug Market Size (K Pcs) and Growth Rate Forecast
Figure Global 2018-2025 Sickle Cell Disease Drug Market Size (Million USD) and Growth Rate Forecast
Figure Global 2018-2025 Sickle Cell Disease Drug Sales Price (USD/Pcs) Forecast
Figure North America 2018-2025 Sickle Cell Disease Drug Consumption Volume (K Pcs) and Growth Rate Forecast
Figure China 2018-2025 Sickle Cell Disease Drug Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Europe 2018-2025 Sickle Cell Disease Drug Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Southeast Asia 2018-2025 Sickle Cell Disease Drug Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Japan 2018-2025 Sickle Cell Disease Drug Consumption Volume (K Pcs) and Growth Rate Forecast
Figure India 2018-2025 Sickle Cell Disease Drug Consumption Volume (K Pcs) and Growth Rate Forecast
Table Global Sales Volume (K Pcs) of Sickle Cell Disease Drug by Type 2018-2025
Table Global Consumption Volume (K Pcs) of Sickle Cell Disease Drug by Application 2018-2025
Table Traders or Distributors with Contact Information of Sickle Cell Disease Drug by Region

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.

Menu 3

Eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.